Literature DB >> 2165138

Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain.

R J Moormann1, T de Rover, J Briaire, B P Peeters, A L Gielkens, J T van Oirschot.   

Abstract

In an earlier report, we described the construction of the genetically engineered pseudorabies virus strain 2.4N3A which does not express glycoprotein gI. Although this strain showed a strongly reduced virulence in 10-week-old seronegative pigs, it could still cause severe disease or death in 3-day-old piglets. To attenuate the strain further, we constructed mutants with a deletion in the viral thymidine kinase gene. One mutant strain, designated 783, has a deletion of 19 base pairs and was shown to be highly immunogenic and safe for vaccination of pigs against pseudorabies virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165138     DOI: 10.1099/0022-1317-71-7-1591

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

Authors:  B T Ober; B Teufel; K H Wiesmüller; G Jung; E Pfaff; A Saalmüller; H J Rziha
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus.

Authors:  T G Kimman
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

4.  Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.

Authors:  M van Zijl; G Wensvoort; E de Kluyver; M Hulst; H van der Gulden; A Gielkens; A Berns; R Moormann
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Development and antigen specificity of the lymphoproliferation responses of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses.

Authors:  T G Kimman; T M De Bruin; J J Voermans; B P Peeters; A T Bianchi
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

6.  Epitope-specific antibody response against glycoprotein E of pseudorabies virus.

Authors:  L Jacobs; T G Kimman
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

7.  Genetic recombination of pseudorabies virus: evidence that homologous recombination between insert sequences is less frequent than between autologous sequences.

Authors:  K L Glazenburg; R J Moormann; T G Kimman; A L Gielkens; B P Peeters
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 8.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

9.  Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.

Authors:  Pinghua Li; Zengjun Lu; Xingwen Bai; Dong Li; Pu Sun; Huifang Bao; Yuanfang Fu; Yimei Cao; Yingli Chen; Baoxia Xie; Hong Yin; Zaixin Liu
Journal:  Vet Res       Date:  2014-05-01       Impact factor: 3.683

10.  Phylogenetic and recombination analysis of the herpesvirus genus varicellovirus.

Authors:  Aaron W Kolb; Andrew C Lewin; Ralph Moeller Trane; Gillian J McLellan; Curtis R Brandt
Journal:  BMC Genomics       Date:  2017-11-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.